Randomized Controlled Trial of the Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

被引:0
|
作者
Gogenur, Mikail [1 ]
Gogenur, Ismail [1 ]
机构
[1] Zealand Univ Hosp, Ctr Surg Sci, Dept Surg, Roskilde, Denmark
关键词
OPEN SURGERY; ANESTHESIA; REDUCTION; MORTALITY;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:E105 / E106
页数:2
相关论文
共 50 条
  • [1] Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
    Chang, Wenju
    Wei, Ye
    Ren, Li
    Zhong, Yunshi
    Yu, Yiyi
    Chen, Jingwen
    Zhu, Dexiang
    Ye, Lechi
    Qin, Chunzhi
    Zhao, Naiqing
    Niu, Weixin
    Qin, Xinyu
    Xu, Jianmin
    ANNALS OF SURGERY, 2016, 263 (03) : 434 - 439
  • [2] Phase II clinical trial of adjuvant chemotherapy with mFOLFOX6/XELOX for stage III colon cancer in Japanese subjects
    Yamada, T.
    Koda, K.
    Ishibashi, K.
    Kato, H.
    Nishimura, G.
    Ooki, S.
    Yoshimatsu, K.
    Uchida, E.
    Kan, H.
    Kosugi, C.
    Tanaka, S.
    Kato, R.
    Kouketsu, S.
    Nakajima, H.
    Maekawa, H.
    Kobayashi, M.
    Tsubaki, M.
    Yokoyama, M.
    Tanakaya, K.
    Ishida, H.
    ANNALS OF ONCOLOGY, 2015, 26 : 55 - 55
  • [3] Improved disease-free survival with intraportal chemotherapy plus adjuvant chemotherapy (mFOLFOX6) as adjuvant treatment in colon cancer.
    Chang, Wenju
    Xu, Jianmin
    Wei, Ye
    Ren, Li
    Liu, Tianshu
    Chen, Jingwen
    Zhu, Dexiang
    Lin, Qi
    Qin, Xinyu
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Comparison of Hematological Toxicity of mFOLFOX6 vs CAPOX Chemotherapy Regimens in Adjuvant Treatment of Stage II-III Colon Cancer Patients
    Harutyunyan, Lilit
    Arakelyan, Jemma
    Safaryan, Liana
    Avagyan, Armen
    Zohrabyan, Davit
    Sargsyan, Lilit
    Hakobyan, Lusine
    Iskanyan, Samvel
    Papyan, Ruzanna
    Harutyunyan, Martin
    Mkrtchyan, Gohar
    Rushanyan, Marine
    Tamamyan, Gevorg
    Danielyan, Samvel
    Jilavyan, Aram
    Tananyan, Armen
    Bardakhchyan, Samvel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S268 - S268
  • [5] Adjuvant chemotherapy with mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Xie, Xiaoyu
    Wu, Zehua
    Ling, Jiayu
    Chen, Dianke
    Liu, Ping
    Kang, Liang
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study)
    Chihiro Kosugi
    Keiji Koda
    Keiichiro Ishibashi
    Kazuhiko Yoshimatsu
    Soichi Tanaka
    Ryouji Kato
    Hiroyuki Kato
    Masatoshi Oya
    Kazuo Narushima
    Mikito Mori
    Kiyohiko Shuto
    Hideyuki Ishida
    International Journal of Colorectal Disease, 2018, 33 : 809 - 817
  • [7] Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study)
    Kosugi, Chihiro
    Koda, Keiji
    Ishibashi, Keiichiro
    Yoshimatsu, Kazuhiko
    Tanaka, Soichi
    Kato, Ryouji
    Kato, Hiroyuki
    Oya, Masatoshi
    Narushima, Kazuo
    Mori, Mikito
    Shuto, Kiyohiko
    Ishida, Hideyuki
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (06) : 809 - 817
  • [8] XELOX or mFOLFOX6 chemotherapy combined with resection of primary lesion versus chemotherapy alone for colon cancer with unresectable metastases: A randomized clinical trial.
    Guo, Weijian
    Li, Xinxiang
    Huang, Mingzhu
    Yang, Ya'nan
    Li, Qingguo
    Wang, Chenchen
    Liang, Lei
    Zhu, Xiaodong
    Zhang, Wen
    Chen, Zhiyu
    Li, Wenhua
    Zhang, Xiaowei
    Zhao, Xiaoying
    Qiu, Lixin
    Geng, Qirong
    Sheng, Xuedan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma
    Labianca, R
    Fossati, R
    Zaniboni, A
    Torri, V
    Marsoni, S
    Nitti, D
    Boffi, L
    Scatizzi, M
    Tardio, B
    Mastrodonato, N
    Banducci, S
    Consani, G
    Pancera, G
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (10): : 750 - 758
  • [10] Adjuvant chemotherapy of stage III colon cancer
    Benson, AB
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S74 - S77